Home > Library
Search results : brexit
2025-07-01Geopolitical alignment often reshapes and reinforces asset market fragmentation in the broader context of financial deglobalization.
2025-01-01The new homeland industrial policy stance tends to tilt toward substantially improving the worldwide resilience of global supply chains.
2024-07-07Central bank digital currencies (CBDC) can affect how the central bank makes macro-financial system and monetary policy decisions in support of the dual mandate of both price stability and maximum employment.
2024-01-01Western governments use the new world order of trade to achieve non-economic goals such as national security, environmental protection, labor harmonization, and technological advancement etc.
2020-02-02This analytic report shines fresh light on the current global economic outlook as of February 2020.
2019-08-07This analytic report shines fresh light on the current global economic outlook as of August 2019.
2019-09-09 20:38:00 Monday ET

Harvard macrofinance professor Robert Barro sees no good reasons for the recent sudden reversal of U.S. monetary policy normalization. As Federal Reserve Ch
2019-09-05 09:26:00 Thursday ET

Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America. Firs
2023-12-10 09:23:00 Sunday ET

U.S. federalism and domestic institutional arrangements A given country is federal when both of its national and sub-national governments exercise separa
2019-03-09 12:43:00 Saturday ET

Pinterest files a $12 billion IPO due in mid-2019. This tech unicorn allows users to pin-and-browse images through its social media app and website. Pintere
2017-11-27 07:39:00 Monday ET

Is it anti-competitive and illegal for passive indexers and mutual funds to place large stock bets in specific industries with high market concentration? Ha
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be